期刊文献+

局部晚期非小细胞肺癌治疗的争议与共识 被引量:3

Treatment of locally advanced non-small cell lung cancer: Agreement and disagreement
在线阅读 下载PDF
导出
摘要 肺癌是发病率和死亡率增长最快 ,对人类健康和生命威胁最大的恶性肿瘤。完全性切除是目前治疗肺癌的最好方法。但是 ,仅有约 1/3的肺癌适合于外科治疗 ,另 2 /3的肺癌由于伴有远处转移或侵犯邻近器官而被视为不可手术。近年来 ,随着心血管外科理论和技术在肺癌外科中的应用 ,使得肺切除合并受侵的左心房、胸主动脉、上腔静脉和肺动脉的整块切除成为可能。这些过去被视为外科禁忌证和无治愈希望的局部晚期肺癌 ,不但获得肿瘤完全切除、无肿瘤复发转移 ,而且获得长期生存和良好的生活质量。 Lung cancer has become the most frequent malignant tumor in the world which its mortality and morbidity is increasing fastest among all the cancers, and it also has become the No.1 malignant tumors which is harmful to human health and life, and the first killer in all cancers. .Complete surgical resection is currently the best treatment modality for lung cancer. However, only one third of patients with lung cancer can be identified as operative candidates, For the other two thirds is inoperable, because they have late disease with distant metastasis or locally advanced lung cancer involving neighboring organs. Recently, introduction of the theory and technique of cardiovascular surgery into lung cancer surgery has made possible en bloc resection of the lung combined with part of the involved left atrium, aorta, superior vena cava, and pulmonary artery. It also made many advances for the patients with locally advanced non-small cell lung cancer lung cancer, who were thought as surgical contraindication or no curable cases, not only got complete resection of the tumor, but also had long-term survival and god life quality without evidence of recurrence and distant metastasis of the cancer.
作者 周清华
出处 《肿瘤防治杂志》 CAS 2004年第7期749-752,共4页 China Journal of Cancer Prevention and Treatment
关键词 非小细胞肺癌 肺肿瘤 综述文献 carcinoma, non-small cell lung lung neoplasms, review literature
  • 相关文献

参考文献16

二级参考文献65

  • 1周清华,杨俊杰.全肺切除合并部分左心房切除术治疗Ⅲb期肺癌:附五例报告[J].中华肿瘤杂志,1993,15(5):388-390. 被引量:10
  • 2周清华,刘伦旭,杨俊杰,张卫红,霍永江,杨振华.肺及部分左心房切除术治疗中心型肺癌[J].中华胸心血管外科杂志,1997,13(1):34-36. 被引量:69
  • 3[1]De Pierre A. Overview of the role for neoadjuvant therapy for early-stage non-small cell lung cancer. Lung Cancer,2000,29(Suppl 2)∶124-125.
  • 4[2]Albain KS, Pass HI. Induction therapy before surgery for non-small cell lung cancer. Lung Cancer,2000,29(Suppl 2)∶168-171.
  • 5[3]De Pierre A, Milleron B, Chevret S, et al. French phase Ⅲ trial of preoperative chemotherapy (PCT) in resectable stage Ⅰ (except T1N0), Ⅱ, Ⅲa non-small cell lung cancer (NSCLC). Lung Cancer,2000,29(Suppl 1)∶91.
  • 6[4]Splinter T, Groen H, Smit E, et al. Randomized multicenter phase Ⅱ study of chemotherapy followed by surgery versus surgery alone in stage Ⅰand Ⅱ non-small cell lung cancer (NSCLC). Lung Cancer,2000,29(Suppl 1)∶90.
  • 7[5]Eberhardt W, Korfee S, Wagner H, et al. "Minimal N2-disease”(operable) stage ⅢA non-small cell lung cancer: Prospectively randomized multicenter German phase-Ⅲ-trial of surgery (S) followed by adjuvant radiotherapy (RTx) versus "Trimodality treatment”-Early results of feasibility and toxicity in this setting. Lung Cancer,2000,29(Suppl 1)∶95-96.
  • 8[6]Mattson K, Ten Valde G, Krofta K, et al. Early results of an international phase Ⅲ study evaluating Taxotere as neo-adjuvant therapy for radically-treatable stage Ⅲ NSCLC. Lung Cancer,2000,29(Suppl 1)∶90.
  • 9[7]O'Rourke N, Armour A. Neo-adjuvant chemotherapy in stage Ⅲ NSCLC in the West of Scotland improves the potential for cure. Lung Cancer,2000,29(Suppl 1)∶107.
  • 10[8]Saito Y, Minami K, Kobayashi M, et al. Ten years' experience of induction therapy for locally advanced NSCLC; a single institution study. Lung Cancer,2000,29(Suppl 1)∶89-90.

共引文献315

同被引文献21

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部